Should the future development of this cream
continue at Mayne average rate . Stage two ,
three then approval 2024-5 would seem fair.
I can see Scott Richards buying another near
approved or on market one to suit our Portfolio.
This will then further increase our Debt. Yet it will
portrayed at how pleased he is to have achieved
such wonderment. This has been his style of
recent management. Pay other Pharmaceutical
companies for their R and D. Yet continue spending
hundreds of millions on ours for zero positive return.
Should the future development of this creamcontinue at Mayne...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |